Cargando…
Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer
BACKGROUND: Microcell-mediated chromosome transfer (MMCT) is a technique by which a chromosome(s) is moved from donor to recipient cells by microcell fusion. Polyethylene glycol (PEG) has conventionally been used as a fusogen, and has been very successful in various genetic studies. However, PEG is...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874513/ https://www.ncbi.nlm.nih.gov/pubmed/20444293 http://dx.doi.org/10.1186/1472-6750-10-37 |
_version_ | 1782181485314310144 |
---|---|
author | Katoh, Motonobu Kazuki, Yasuhiro Kazuki, Kanako Kajitani, Naoyo Takiguchi, Masato Nakayama, Yuji Nakamura, Takafumi Oshimura, Mitsuo |
author_facet | Katoh, Motonobu Kazuki, Yasuhiro Kazuki, Kanako Kajitani, Naoyo Takiguchi, Masato Nakayama, Yuji Nakamura, Takafumi Oshimura, Mitsuo |
author_sort | Katoh, Motonobu |
collection | PubMed |
description | BACKGROUND: Microcell-mediated chromosome transfer (MMCT) is a technique by which a chromosome(s) is moved from donor to recipient cells by microcell fusion. Polyethylene glycol (PEG) has conventionally been used as a fusogen, and has been very successful in various genetic studies. However, PEG is not applicable for all types of recipient cells, because of its cell type-dependent toxicity. The cytotoxicity of PEG limits the yield of microcell hybrids to low level (10(-6 )to 10(-5 )per recipient cells). To harness the full potential of MMCT, a less toxic and more efficient fusion protocol that can be easily manipulated needs to be developed. RESULTS: Microcell donor CHO cells carrying a human artificial chromosome (HAC) were transfected with genes encoding hemagglutinin (H) and fusion (F) proteins of an attenuated Measles Virus (MV) Edmonston strain. Mixed culture of the CHO transfectants and MV infection-competent human fibrosarcoma cells (HT1080) formed multinucleated syncytia, suggesting the functional expression of the MV-H/F in the CHO cells. Microcells were prepared and applied to HT1080 cells, human immortalized mesenchymal stem cells (hiMSC), and primary fibroblasts. Drug-resistant cells appeared after selection in culture with Blasticidin targeted against the tagged selection marker gene on the HAC. The fusion efficiency was determined by counting the total number of stable clones obtained in each experiment. Retention of the HAC in the microcell hybrids was confirmed by FISH analyses. The three recipient cell lines displayed distinct fusion efficiencies that depended on the cell-surface expression level of CD46, which acts as a receptor for MV. In HT1080 and hiMSC, the maximum efficiency observed was 50 and 100 times greater than that using conventional PEG fusion, respectively. However, the low efficiency of PEG-induced fusion with HFL1 was not improved by the MV fusogen. CONCLUSIONS: Ectopic expression of MV envelope proteins provides an efficient recipient cell-oriented MMCT protocol, facilitating extensive applications for studies of gene function and genetic corrections. |
format | Text |
id | pubmed-2874513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28745132010-05-22 Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer Katoh, Motonobu Kazuki, Yasuhiro Kazuki, Kanako Kajitani, Naoyo Takiguchi, Masato Nakayama, Yuji Nakamura, Takafumi Oshimura, Mitsuo BMC Biotechnol Research article BACKGROUND: Microcell-mediated chromosome transfer (MMCT) is a technique by which a chromosome(s) is moved from donor to recipient cells by microcell fusion. Polyethylene glycol (PEG) has conventionally been used as a fusogen, and has been very successful in various genetic studies. However, PEG is not applicable for all types of recipient cells, because of its cell type-dependent toxicity. The cytotoxicity of PEG limits the yield of microcell hybrids to low level (10(-6 )to 10(-5 )per recipient cells). To harness the full potential of MMCT, a less toxic and more efficient fusion protocol that can be easily manipulated needs to be developed. RESULTS: Microcell donor CHO cells carrying a human artificial chromosome (HAC) were transfected with genes encoding hemagglutinin (H) and fusion (F) proteins of an attenuated Measles Virus (MV) Edmonston strain. Mixed culture of the CHO transfectants and MV infection-competent human fibrosarcoma cells (HT1080) formed multinucleated syncytia, suggesting the functional expression of the MV-H/F in the CHO cells. Microcells were prepared and applied to HT1080 cells, human immortalized mesenchymal stem cells (hiMSC), and primary fibroblasts. Drug-resistant cells appeared after selection in culture with Blasticidin targeted against the tagged selection marker gene on the HAC. The fusion efficiency was determined by counting the total number of stable clones obtained in each experiment. Retention of the HAC in the microcell hybrids was confirmed by FISH analyses. The three recipient cell lines displayed distinct fusion efficiencies that depended on the cell-surface expression level of CD46, which acts as a receptor for MV. In HT1080 and hiMSC, the maximum efficiency observed was 50 and 100 times greater than that using conventional PEG fusion, respectively. However, the low efficiency of PEG-induced fusion with HFL1 was not improved by the MV fusogen. CONCLUSIONS: Ectopic expression of MV envelope proteins provides an efficient recipient cell-oriented MMCT protocol, facilitating extensive applications for studies of gene function and genetic corrections. BioMed Central 2010-05-06 /pmc/articles/PMC2874513/ /pubmed/20444293 http://dx.doi.org/10.1186/1472-6750-10-37 Text en Copyright ©2010 Katoh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article Katoh, Motonobu Kazuki, Yasuhiro Kazuki, Kanako Kajitani, Naoyo Takiguchi, Masato Nakayama, Yuji Nakamura, Takafumi Oshimura, Mitsuo Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title | Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title_full | Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title_fullStr | Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title_full_unstemmed | Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title_short | Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer |
title_sort | exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor cd46 on human cells for microcell-mediated chromosome transfer |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874513/ https://www.ncbi.nlm.nih.gov/pubmed/20444293 http://dx.doi.org/10.1186/1472-6750-10-37 |
work_keys_str_mv | AT katohmotonobu exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT kazukiyasuhiro exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT kazukikanako exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT kajitaninaoyo exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT takiguchimasato exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT nakayamayuji exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT nakamuratakafumi exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer AT oshimuramitsuo exploitationoftheinteractionofmeaslesvirusfusogenicenvelopeproteinswiththesurfacereceptorcd46onhumancellsformicrocellmediatedchromosometransfer |